; privacy protections (1) Voluntary participation Participation in the registry described in subsection (b)(1) shall be voluntary, and a person creating, assisting in the creation of, or maintaining the registry shall not include in the registry information about an individual unless the individual consents to the inclusion of such information. (2) Privacy protections Information about an individual that is included in the registry shall be subject to all applicable privacy protections under Federal and State law. (d) Report Not later than 1 year after the establishment of the synthesized patient registry under subsection (b)(2), and annually thereafter, the Secretary shall submit a report that includes data, findings, and information with respect to the status of the patient registry (including progress, barriers, and issues) to Congress and the President. (e) Authorization of appropriations To carry out this section, there is authorized to be appropriated $30,000,000 for fiscal year 2024, which shall remain available until expended. 3. Research on United States health care system’s response to Long COVID (a) In general The Secretary, in coordination with the Director of the Agency for Healthcare Research and Quality, the Director of the National Institutes of Health, and the Director of the Centers for Disease Control and Prevention, shall conduct or support research related to the United States health care system’s response to Long COVID, including with respect to— (1) the expansion and effectiveness of post-infectious disease treatment, including— (A) identifying barriers to access for treatment of COVID–19, Long COVID, and related conditions for veterans, older adults, people with disabilities, children and young adults, communities of color, underserved and rural communities, and other groups impacted by high rates of COVID–19, as determined by the Secretary